KLK1作为表皮特异性抑制剂通过抑制B1R介导的纤维细胞表型转变来抑制结肠直肠瘤发生
在PubMed上查看摘要
概括
此摘要是机器生成的。Kallikrein-1 (KLK1) 补充剂可以预防炎症性肠病 (IBD) 和结肠炎相关的结肠直肠癌 (CAC). KLK1有助于维持肠道屏障的完整性和正常的树皮功能,提供治疗潜力.
科学领域
- 胃肠病学
- 癌症学
- 分子生物学
背景情况
- 炎症性肠病 (IBD) 是一个日益严重的全球健康问题.
- 在IBD中,慢性炎症可能发展为结肠炎相关的结肠直肠癌 (CAC).
- 卡利克林-1 (KLK1) 在肠道健康中的作用及其潜在的治疗应用仍在研究中.
研究的目的
- 在结肠炎和结肠直肠癌的模型中研究KLK1补充剂的保护作用.
- 阐明KLK1影响肠道屏障完整性和结构稳定性的机制.
- 在人类IBD和结直肠癌样本中评估KLK1水平.
主要方法
- 使用德克斯硫酸盐 (DSS) 和亚甲 (AOM) 诱导的大肠炎/CAC小鼠模型.
- 使用KLK1-AAV2敲击小鼠来评估KL1缺陷的影响.
- 分析了性结肠炎患者和结肠直肠癌样本的临床样本.
- 研究了布拉迪基宁受体B1 (B1R) 和细胞外基质 (ECM) 途径的作用.
主要成果
- 导致大肠炎症状恶化和粘膜屏障功能受损.
- 在人类性结肠炎和结直肠癌样本中观察到KLK1表达的减少.
- 补充KL1可以逆转DSS/ AOM引起的病理变化,包括屏障破坏和结构重塑.
- 布拉迪基宁受体B1 (B1R) 的上调和随后的ECM通路激活与CAC的发病有关.
结论
- 在维护肠上皮屏障完整性方面,KLK1起着至关重要的作用.
- KLK1补充剂在预防结肠炎和结肠直肠癌方面具有治疗潜力.
- KLK1调节纤维细胞与细胞外矩阵的相互作用,为IBD和CAC的发病提供了新的见解.
相关概念视频
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...

